Despite plasma concentrations of drug consistent with > @ % receptor occupancy during the dosing period , the CCR@ antagonist did not significantly reduce eosinophils or eosinophil progenitor cells ( CD@ ( + ) @ ( + ) IL-@R ( + ) ) in sputum or in blood .